Dr. Ido Bachelet
Bachelet, Ph.D. is Assistant Professor in Medicine and Life Science
Institute for Nanotechnology and Advanced Materials, Bar-Ilan
His main research areas are:
molecular programming, nanomechanics of biological components, and
He is also group leader of the REBIT team, a multidisciplinary group developing and studying emerging biologically-inspired technologies. Their research spans a wide array of fields, ranging from synthetic biology, DNA machines and computers, nanorobotics, and swarm intelligence to architecture, physical computing, design, art, and interfaces between the physical and digital worlds.
His papers include The Inhibitory Receptor IRp60 (CD300a) Is Expressed and Functional on Human Mast Cells, The third wave of myotome colonization by mitotically competent progenitors: regulating the balance between differentiation and proliferation during muscle development, 2B4 (CD244) Is Expressed and Functional on Human Eosinophils, The sub-lip domain — a distinct pathway for myotome precursors that demonstrate rostral-caudal migration, CD48 Is an Allergen and IL-3-Induced Activation Molecule on Eosinophils, and Targeting an antimicrobial effector function in insect immunity as a pest control strategy.
Ido earned his Ph.D. in Pharmacology and Experimental Pharmaceutics at Hebrew University, Israel. He did his postdoctoral work at MIT and Harvard Medical School. He is winner of the 2007 Barenholz Prize for Creativity and Originality in Applied Research for his approach to eliminating allergies and asthma.
Watch “DNA Origami” Nanorobots Could Find and Destroy Cancer Cells. Read Researchers at Harvard’s Wyss Institute Develop DNA Nanorobot to Trigger Targeted Therapeutic Responses and No More Choking And Burning Eyes? New Approach To Eliminating Allergies, Asthma. Read his LinkedIn profile.